查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1965344

铁蛋白检测市场 - 全球产业规模、份额、趋势、机会、预测：按产品、应用、最终用途、地区和竞争对手划分，2021-2031年

Ferritin Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球铁蛋白检测市场预计将从 2025 年的 16.7 亿美元成长到 2031 年的 25.9 亿美元，复合年增长率为 7.59%。

血清铁蛋白检测是重要的临床诊断工具，它能够量化血清铁蛋白水平，从而清晰评估全身铁蕴藏量，并识别贫血和铁过载等疾病。营养缺乏症发病率的上升以及慢性疾病（如肾衰竭）管理中对铁监测的迫切需求，推动了这个市场的发展。根据美国血液学会2024年的数据，美国青少年和年轻女性的缺铁盛行率可能高达39%，凸显了对诊断干预措施的巨大需求。

市场概览
预测期 2027-2031
市场规模：2025年 16.7亿美元
市场规模：2031年 25.9亿美元
复合年增长率：2026-2031年 7.59%
成长最快的细分市场 成套工具
最大的市场 北美洲

儘管成长要素强劲，但市场仍面临一个重大障碍：用于精确检测的自动化免疫检测系统高成本。新兴经济体缺乏先进的检查室基础设施，进一步加剧了这项资金限制，导致铁蛋白检测的普及程度降低。因此，这些经济和基础设施障碍限制了发展中地区的市场准入，阻碍了整体成长，儘管临床上对铁监测的需求十分明确。

市场驱动因素

全球缺铁性贫血盛行率的上升正成为市场扩张的主要催化剂，也使得频繁的诊断筛检成为避免长期健康併发症的迫切需求。显性贫血和隐性缺铁之间的差距扩大了目标人口，并促使铁蛋白检测成为常规检查项目。美国血液学会于2025年11月发布的一项系统性综述报告称，在不同的铁蛋白阈值下，缺铁的合併盛行率为30%，这表明存在大量未确诊的患者群体。这项数据，结合美国疾病管制与预防中心（CDC）2024年的数据（2岁及以上族群的贫血总体盛行率为9.3%），凸显了血液学监测的根本需求，而这正是全球市场发展的基石。

老年人口的快速成长，尤其是慢性肾臟病等慢性疾病的易感族群，进一步加剧了对精准铁蛋白监测的需求。对于合併多种疾病的老年患者，区分缺铁性贫血和慢性病相关性贫血对于采取适当的治疗措施至关重要。发表于2025年1月《营养学杂誌》的一项研究发现，27.2%的非透析慢性肾臟病患者的铁蛋白水平低于100 ng/mL，这凸显了对该人群铁蕴藏量进行仔细评估的必要性。随着医疗系统将慢性病管理置于优先地位以降低再入院率，铁蛋白检测作为老年照护核心诊断工具的重要性也日益凸显。

市场挑战

全球铁蛋白检测市场扩张的主要障碍是自动化免疫检测系统的高昂成本，而发展中地区检测基础设施的匮乏更使这问题雪上加霜。精确的铁蛋白测量需要复杂的诊断平台，这需要大量的初始资本投入和持续的营运资金。在医疗预算有限的新兴经济体，这种经济负担阻碍了关键设备的广泛应用，实际上将需要铁监测的潜在患者群体排除在外。

监管合规和设备维护成本的不断上涨加剧了这一经济负担，迫使製造商将这些成本转嫁给检测实验室。根据 MedTech Europe 发布的 2025 年行业调查报告，体外诊断设备製造商预计将面临相当于标准认证週期内初始认证成本 70% 的维护和再认证成本。这些不断上涨的成本推高了自动化系统的总拥有成本，使其对于资源有限的机构而言在经济上不可行。因此，儘管缺铁症的盛行率不断上升，市场仍难以渗透到需求旺盛的开发中国家，这直接阻碍了全球收入成长。

市场趋势

家用和自测检测套组的普及检测套组从根本上改变市场结构，使诊断服务分散化，并创造了一个患者无需前往临床检查室即可自行监测铁蕴藏量的环境。这一趋势主要得益于面向消费者的数位化销售管道的成长，这些管道绕过了传统医疗保健系统的瓶颈，使个人能够直接订购和接受诊断试剂盒。毛细血管采血的简单性和数位化结果交付的便利性吸引了注重健康的消费者，并有效地规避了集中检测的基础设施限制。例如，Quest Diagnostics 在 2025 年 1 月的财报中宣布，其以消费者主导的平台将扩展其检测范围至约 135 种，包括微量营养素缺乏症，并增强对基本代谢监测的可及性。

同时，基于智慧型手机的诊断平台的整合正在彻底改变铁蛋白定量检测的速度和成本，尤其是在资源匮乏的环境中。透过利用标准行动装置的高解析度成像功能，开发人员正在创建比色分析工具，从而无需昂贵的固定式光强度。这些携带式解决方案使用客製化应用程式分析微流体试纸上的反应变化，即使在非检测环境下也能提供即时的临床数据。正如《康乃尔纪事报》2024年12月报道，基于智慧型手机的诊断技术「AnemiaPhone」已正式移交给印度医学研究委员会，实现了对缺铁的快速现场筛检。这充分展现了行动互联诊断技术的扩充性。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球铁蛋白检测市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依产品分类（仪器、试剂、试剂盒）
    • 依用途（贫血、血铁沉着症、铅中毒、怀孕、其他）
    • 依最终用户（医院、诊断检查室）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美铁蛋白检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲铁蛋白检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区铁蛋白检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲铁蛋白检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲铁蛋白检测市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球铁蛋白检测市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Eurolyser Diagnostica GmbH
  • Cortez Diagnostics Inc.
  • Thermo Fisher Scientific Inc.
  • Biomerieux SA
  • Aviva Systems Biology Corporation
  • Abnova Corporation
  • CTK Biotech Inc.
  • Randox Laboratories Ltd.
  • Guangzhou Wondfo Biotech Co., Ltd.
  • F. Hoffmann-La Roche Ltd.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 27300

The Global Ferritin Testing Market is projected to expand from USD 1.67 Billion in 2025 to USD 2.59 Billion by 2031, registering a CAGR of 7.59%. Ferritin testing serves as a critical clinical diagnostic method for quantifying serum ferritin levels, offering a definitive evaluation of total body iron reserves to identify conditions such as anemia or iron overload. The market is consistently driven by the rising incidence of nutritional deficiencies and the essential requirement for iron monitoring in the management of chronic diseases like renal failure. Data from the American Society of Hematology in 2024 indicates that the prevalence of iron deficiency among adolescent and young adult women in the United States could be as high as 39%, highlighting the substantial demand for diagnostic intervention.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.67 Billion
Market Size 2031USD 2.59 Billion
CAGR 2026-20317.59%
Fastest Growing SegmentKits
Largest MarketNorth America

Despite these strong growth factors, the market faces a major hurdle due to the high costs associated with the automated immunoassay systems needed for precise testing. This financial constraint, exacerbated by a lack of advanced laboratory infrastructure in emerging economies, restricts the availability of ferritin testing. Consequently, these economic and infrastructural barriers limit market accessibility in developing regions, constraining overall growth despite the clear clinical need for iron monitoring.

Market Driver

The increasing global prevalence of iron deficiency anemia acts as a primary catalyst for market expansion, creating a pressing need for frequent diagnostic screening to avert long-term health complications. The gap between overt anemia and latent iron deficiency expands the target population for testing, encouraging the routine adoption of ferritin assays. A November 2025 systematic review by the American Society of Hematology revealed a pooled iron deficiency prevalence of 30% across various ferritin thresholds, suggesting a large, under-diagnosed patient pool. This figure, combined with 2024 data from the Centers for Disease Control and Prevention showing a 9.3% overall anemia prevalence in individuals aged two and older, reinforces the fundamental demand for hematological monitoring that supports the global market.

The rapidly growing geriatric population, which is susceptible to chronic ailments such as chronic kidney disease, further accelerates the demand for accurate ferritin monitoring. In elderly patients with complex comorbidities, distinguishing between iron deficiency anemia and anemia of chronic disease is vital for proper therapeutic action. A January 2025 study in the Nutrition Journal reported that 27.2% of non-dialysis chronic kidney disease patients had ferritin levels at or below 100 ng/mL, emphasizing the necessity for vigilant iron store evaluation in this demographic. As healthcare systems increasingly prioritize the management of chronic conditions to reduce hospital readmissions, the reliance on ferritin testing as a core diagnostic tool in geriatric care continues to intensify.

Market Challenge

The main impediment to the expansion of the Global Ferritin Testing Market is the prohibitive expense associated with automated immunoassay systems, compounded by a shortage of adequate laboratory infrastructure in developing regions. Precise ferritin measurement relies on advanced diagnostic platforms that require significant upfront capital investment and substantial ongoing operational funding. In emerging economies where healthcare budgets are often limited, this financial burden hinders the widespread installation of necessary equipment, creating an entry barrier that effectively excludes a large demographic of potential patients who require iron monitoring.

This economic strain is further intensified by the escalating costs of regulatory compliance and device maintenance, which manufacturers inevitably pass on to laboratories. Industry survey findings from MedTech Europe in 2025 project that manufacturers of in vitro diagnostics will face maintenance and re-certification costs that are 70% higher than initial certification fees over a standard cycle. These rising expenses increase the total cost of ownership for automated systems, making them financially unviable for resource-constrained facilities. Consequently, the market struggles to penetrate high-need developing nations, directly hampering global revenue growth despite the rising prevalence of iron deficiency.

Market Trends

The proliferation of at-home and self-testing kits is fundamentally reshaping the market by decentralizing diagnostic access and empowering patients to monitor iron stores without visiting clinical laboratories. This trend is largely supported by the growth of direct-to-consumer digital sales channels, which allow individuals to order and receive diagnostic kits directly, bypassing traditional healthcare bottlenecks. The convenience of capillary blood collection combined with digital result delivery appeals to health-conscious demographics, effectively circumventing the infrastructure limitations of centralized testing. For instance, Quest Diagnostics reported in their January 2025 financial results that their consumer-initiated platform had expanded to cover approximately 135 tests, including micronutrient deficiencies, thereby broadening access to essential metabolic monitoring.

Simultaneously, the integration of smartphone-based diagnostic platforms is revolutionizing the speed and affordability of ferritin quantification, particularly in resource-limited settings. By leveraging the high-resolution imaging capabilities of standard mobile devices, developers are creating colorimetric analysis tools that eliminate the need for expensive, stationary spectrophotometers. These portable solutions utilize custom applications to analyze reaction changes on microfluidic strips, offering immediate clinical data in non-laboratory environments. As highlighted by the Cornell Chronicle in December 2024, a smartphone-based diagnostic technology named AnemiaPhone was formally transferred to the Indian Council of Medical Research to enable rapid, point-of-need screening for iron deficiency, illustrating the scalability of mobile-linked diagnostics.

Key Market Players

  • Eurolyser Diagnostica GmbH
  • Cortez Diagnostics Inc.
  • Thermo Fisher Scientific Inc.
  • Biomerieux S.A
  • Aviva Systems Biology Corporation
  • Abnova Corporation
  • CTK Biotech Inc.
  • Randox Laboratories Ltd.
  • Guangzhou Wondfo Biotech Co., Ltd.
  • F. Hoffmann-La Roche Ltd.

Report Scope

In this report, the Global Ferritin Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ferritin Testing Market, By Product

  • Instrument
  • Reagent
  • Kits

Ferritin Testing Market, By Application

  • Anaemia
  • Hemochromatosis
  • Lead Poisoning
  • Pregnancy
  • Others

Ferritin Testing Market, By End Use

  • Hospitals
  • Diagnostic Laboratories

Ferritin Testing Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ferritin Testing Market.

Available Customizations:

Global Ferritin Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Ferritin Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Instrument, Reagent, Kits)
    • 5.2.2. By Application (Anaemia, Hemochromatosis, Lead Poisoning, Pregnancy, Others)
    • 5.2.3. By End Use (Hospitals, Diagnostic Laboratories)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Ferritin Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Ferritin Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End Use
    • 6.3.2. Canada Ferritin Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End Use
    • 6.3.3. Mexico Ferritin Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End Use

7. Europe Ferritin Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Ferritin Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End Use
    • 7.3.2. France Ferritin Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End Use
    • 7.3.3. United Kingdom Ferritin Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End Use
    • 7.3.4. Italy Ferritin Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End Use
    • 7.3.5. Spain Ferritin Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End Use

8. Asia Pacific Ferritin Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End Use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Ferritin Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End Use
    • 8.3.2. India Ferritin Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End Use
    • 8.3.3. Japan Ferritin Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End Use
    • 8.3.4. South Korea Ferritin Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End Use
    • 8.3.5. Australia Ferritin Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End Use

9. Middle East & Africa Ferritin Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End Use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Ferritin Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End Use
    • 9.3.2. UAE Ferritin Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End Use
    • 9.3.3. South Africa Ferritin Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End Use

10. South America Ferritin Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End Use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Ferritin Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End Use
    • 10.3.2. Colombia Ferritin Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End Use
    • 10.3.3. Argentina Ferritin Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Ferritin Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Eurolyser Diagnostica GmbH
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cortez Diagnostics Inc.
  • 15.3. Thermo Fisher Scientific Inc.
  • 15.4. Biomerieux S.A
  • 15.5. Aviva Systems Biology Corporation
  • 15.6. Abnova Corporation
  • 15.7. CTK Biotech Inc.
  • 15.8. Randox Laboratories Ltd.
  • 15.9. Guangzhou Wondfo Biotech Co., Ltd.
  • 15.10. F. Hoffmann-La Roche Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer